BIOTIME, INC. 8-K 9-17-2015

Company

Lineage Cell Therapeutics, Inc.

Filed

September 18, 2015

Period of Report

September 17, 2015

Accession Number

0001140361-15-035499

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →